Company
Overview
For Investors
News
Team
Executive Board
Management Team
Scientific Advisory Board
Pertussis
Whooping Cough
B. pertussis
Bacteria
Treatment vs Prevention
Subclinical Colonization + Transmission
Adult/adolescent Boosters
Our Science
BPZE1 Vaccine
Why a Live Vaccine?
Preventing Colonization + Transmission
Preclinical Safety
BPZE1 Publications
Disease Science
- Alzheimer’s Disease
- Allergic Disease
- Autoimmune Disease
Clinical
Opportunity
Market
Pipeline
Intellectual Property
B-Tech
Targeting Disease
with
B-Tech
B-Tech
Vector Platform
Vaccine Candidates
B. Pertussus
Disease Research
BioLyo Tech
Contact
Company
Overview
For Investors
News
Join Our Mailing List
Keith Rubin, CEO
World Vaccine & Immunotherapy Congress
November 28, 2018
Copyright 2013-2022 ILiAD Biotechnologies
